HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

Governance Hansoh Pharmaceutical Group Company Limited

3692

KYG549581067

Pharmaceuticals

Delayed Hong Kong S.E. Other stock markets 08:46:17 08/07/2025 BST			5-day change	1st Jan Change
30.70 ^HKD	-0.97%		+1.49%	+77.66%

06-04	Hansoh Pharmaceutical Group Company Limited Announces Approval of Aumolertinib Mesilate Tablets by the Medicines and Healthcare Products Regulatory Agency for Marketing	CI
06-04	Hansoh Pharmaceutical Says Aumolertinib Mesilate Tablets Approved By MHRA For Marketing	RE

Executive Committee: Hansoh Pharmaceutical Group Company Limited

Manager

Positions heldSince

Hui Juan Zhong

64 year

Chief Executive Officer	01/12/2015
Founder	01/12/2015

Sheng Li Zhong

57 year

Corporate Secretary

31/07/2018

Yuen Ki Wong

36 year

Corporate Secretary

23/01/2025

Composition of the Board of Directors: Hansoh Pharmaceutical Group Company Limited

Director

CommitteesSince

Hui Juan Zhong

64 year

Compensation Committee	01/12/2015
Nominating Committee Chair	22/12/2021

Dong Tao Yang

68 year

Audit Committee	07/10/2021
Governance Committee	27/06/2021
Compensation Committee Chair
Compensation Committee
Nominating Committee	07/10/2021
Nominating Committee Chair

Sheung Wai Chan

71 year

Compensation Committee	30/01/2021
Nominating Committee	30/01/2021
Audit Committee Chair	30/01/2021
Governance Committee	27/06/2021

Guo Qiang Lin

82 year

Audit Committee	30/05/2019
Compensation Committee	30/05/2019
Nominating Committee	30/05/2019

Ai Feng Lyu

48 year

Governance Committee Chair

27/06/2021

Yu An Sun

38 year

Director/Board Member

01/12/2015

Latest Appointments: Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limited Announces Changes to Company Secretary	01-24	CI
Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024	29/04/24	CI
Hansoh Pharmaceutical Group Company Limited Announces Board Appointments	23/12/21	CI
Hansoh Pharmaceutical Group Company Limited Announces Resignation of Ma Cuifang as Non-Executive Director	06/09/21	CI

More news

Former Officers and Directors: Hansoh Pharmaceutical Group Company Limited

Insider

Positions held

SinceUntil

Yan Wing Li

Corporate Secretary

28/04/2024

Cui Fang Ma

Director/Board Member

10/03/2016

05/09/2021

Yao Chang Xu

Corporate Officer/Principal

29/02/2012

29/02/2016

Pik Yuk Cheng

Corporate Secretary

Age distribution of managers

Parity Men Women

Male	4
Female	4

Of which Executive Committee

Male	0
Female	3

Of which Directors

Male	4
Female	2

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

ESG MSCI

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Companyâs innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Companyâs drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.

Employees

8,989

Sector

Pharmaceuticals

Calendar

08-26 - Q2 2025 Earnings Release (Projected)

More about the company